Block B Lecture 3 - Therapeutic Uses of Adrenoceptor Drugs Flashcards
What are 2 scenarios where you would want to manually activate the fight or flight response?
If the patient is experiencing anaphylactic shock or cardiac arrest
(Slide 3)
Why would you want to try and manually activate the fight or flight response in a patient who is experiencing anaphylactic shock?
To maintain blood pressure (as blood pressure drops rapidly during anaphylactic shock) and to open airways so the patient can breathe easier as anaphylactic shock causes bronchoconstriction
(Slide 3)
Why would you want to try and manually activate the fight or flight response in a patient who is experiencing cardiac arrest?
To constrict peripheral blood vessels to maintain flow to vital organs and to stimulate the heart
(Slide 3)
What is xylazine?
An anaesthetic used in veterinary medicine, which is usually used as an adjunct, which reduces the amount of other anaesthetics needed. It also increases the effects of opioids and other drugs
(Slide 5)
What harmful effect can xylazine cause when used by humans in illicit drug mixtures?
Necrotic skin ulcers
(Slide 5)
What 3 uses do α1-adrenoceptor agonists have?
Nasal decongestants - constrict blood vessels in nasal passages to clear up the airway
Management of shock-associated hypotension - increase blood pressure by constricting blood vessels
Pupil Dilation - constricts the dilator muscle of the iris, allowing optometrists to examine the interior of the eye
(Slide 10)
What are the primary use of α2-adrenoceptor agonists?
To reduce blood pressure by inhibiting noradrenaline release or via central mechanisms (processes or actions that occur within the CNS)
(Slide 12)
Is methyldopa active as soon as it is adminestrated?
No it has to be metabolised by the body to become α-methyldopamine and then to α-methylnoradrenaline
(Slide 14)
What are 2 reasons that non-selective α-antagonists are not widely used?
In recent years the availability of more specific treatments have phased them out.
They can produce varying, sometimes even opposing effects, such as:
α1-antagonism in arteries leading to vasodilation and reflex tachycardia, and α2-antagonism in vascular nerves leading to vasoconstriction and reflex bradycardia. α2-antagonism in cardiac sympathetic nerves also just causes reflex tachycardia and leads to heart dysthymia and that’s probably bad.
(Slide 16)
How do α1-antagonists lower blood pressure?
Although α1-antagonism actually causes vasodilation in arteries, this can lead to reflex tachycardia which contributes to a higher blood pressure, but this is offset by them vasodilating veins resulting in a decreased venous return and stroke volume
REMEMBER: BP = CO X PVR
CO = HR X STROKE VOLUME
(Slide 19)
What were α1-antagonists used to treat and what is their recommended use now?
They were used to treat high blood pressure (they are antihypertensives) but are now only recommended to be used for resistant hypertension or to treat benign prostatic hyperplasia
(Slides 20 and 21)
What are 3 examples of α1-antagonists prescribed for high blood pressure and how long do they act for?
Doxazosin (long acting)
Terazosin (long acting)
Prazosin (short acting)
Indoramin (short acting)
(Slide 20)
What is benign prostatic hyperplasia (BPH)?
A common disorder in aging men where the prostate gland becomes enlarged but it isn’t cancerous, which can result in increased frequency of urination, urgency to urinate or struggling to urinate
(Slide 21)
What are 2 α1-antagonists prescribed to treat benign prostatic hyperplasia (BPH)?
Alfuzosin
Doxazosin
Tamsulosin
Terazosin
(Slide 22)
How do α1-antagonists treat benign prostatic hyperplasia (BPH)?
They relax smooth muscle in the prostate gland and neck of the bladder to reduce obstruction of the urethra and reduce restriction of urine flow
(Slide 22)
What is postural hypotension?
A decrease in blood pressure when you stand up after sitting or lying down
(Slide 23)
What are 4 side effects of clonidine (α2-agonist)?
Postural hypotension
Erectile dysfunction / failure to ejaculate
Drowsiness
Rebound hypotension
(Slide 23)